Inscopix
Business Services · California, United States · 51-200 Employees
View Company Info for Free
Overview
Headquarters
1212 Terra Bella Ave Ste 200, Mountain V...Phone Number
(650) 600-3886Website
www.inscopix.comRevenue
$13.4 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
2
1
1
2
1
1
About Inscopix
Inscopix empowers the development of next-generation therapeutics for difficult-to-treat brain disorders by enabling innovative research and predictive preclinical therapeutic development. Driven by a North Star of overcoming historic challenges in the field, Inscopix provides validated solutions for real-time mapping of neural activity in brain circuits. These objective, quantitative and in-brain assays are catalyzing unprecedented insights into disease mechanisms and have been shown to be more accurate at predicting clinical efficacy than animal behavior when testing a therapeutic candidate's capacity to bring the brain back to a normal state. Inscopix's partner and customer discoveries help decode the brain, inform deeper understanding of mechanisms of action and enable the screening of drugs based on efficacy.Explore more
Inscopix Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Inscopix your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Funding: Get notified immidiatlly once Inscopix has new funding data
Check out if Inscopix is spiking on competitors!
Congratulate Masked Content for being promoted to Masked Content at Inscopix
Earning: See what the market has to say on Inscopix recently announced quarterly report
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Website visits: Recent activity has been detected on your website
Click to see if Inscopix had a recent Job posting/layoffs
Inscopix, which may be a good buyer, showed buying intent in Masked Content Topic
Product Launch: Get notified when Inscopix launches new products
Check if Inscopix has recently received funding, and reach out quickly before it becomes old news!
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find more new buyers
Compare Similar Companies to Inscopix
Compare insights from companies similar to Inscopix, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Inscopix
$13.4M
51-200
Private
$11M
2010
SM
Sarah MacNameeWestern Markets Senior Director, Commercial Operations
Company Profile Activity
Activity Insights
Inscopix is experiencing very low activity levels compared to other companies in the Business Services sector.
What does this means?
Inscopix is drawing exceptional interest within the Business Services industry, suggesting notable developments or strong market momentum, learn more about Inscopix.
Inscopix financials insights
Gather financial insights about Inscopix, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2016
Series A
$10M
2020
Debt
$1M
Inscopix Tech Stack
A closer look at the technologies used by Inscopix
See more technologies
Most Recent Scoops
Facilities Relocation / Expansion
Inscopix is planning to move offices in June 2024. The move will impact employees at the existing office located at 1212 Terra Bella Ave, Suite # 200, Mountain View, CA.
Facilities Relocation/Expansion
Left Company
Executive Move
Mergers & Acquisitions (M&A)
Mergers & Acquisitions (M&A)
Mergers & Acquisitions
Open Position
Inscopix News & Media
Bruker Announces Acquisition of Inscopix for Neuroscience Research
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)---- $BRKR #BRKR--Bruker Corporation (Nasdaq: BRKR) today announced the acquisition of Inscopix, Inc., a neuroscience pioneer and market leader of miniaturized microscopes, known as miniscopes, for freely moving animal brain imaging. Since its founding in 2011, Inscopix's flagship miniscope systems have been deployed in over 600 research institutions and biopharma companies worldwide, empowering breakthroughs in fundamental neuroscience research and advancinInscopix Expands Cloud-Based IDEAS Platform for Individual Lab Use
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- #IDEAS--Inscopix is expanding availability of its Data Exploration, Analysis and Sharing (IDEAS) platform to improve how individual labs use neuroscience dataInscopix Showcases New Products and Key Scientific Presentations from Customers at the 52nd Annual Meeting of the Society for Neuroscience
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- #IDEAS--Inscopix will showcase the latest innovations for its brain imaging platform at the Society for Neuroscience meeting in San Diego, Nov 12-16, 2022.Inscopix CEO Kunal Ghosh, PhD Named to PharmaVoice 100
MOUNTAIN VIEW, Calif.--(BUSINESS WIRE)-- #CEO--Inscopix, Inc., a neuroscience company helping decode the brain for tomorrow’s treatments, today announced that Kunal Ghosh, PhD, Chief Executive Officer of Inscopix, has been named to the PharmaVoice 100 — an annual list that recognizes the most inspiring people in the life-sciences industry. “I’m excited to be selected to the 2022 PharmaVoice 100 and honored to share this recognition with top-leading innovators in the life sciences industry,” said
Read more news
Top Business Services Companies
Top companies in Canada by revenue
Frequently Asked Questions Regarding Inscopix
Sign Up For FreeTo access detailed company insights
Inscopix empowers the development of next-generation therapeutics for difficult-to-treat brain disorders by enabling innovative research and predictive preclinical therapeutic development. Driven by a North Star of overcoming historic challenges in the field, Inscopix provides validated solutions for real-time mapping of neural activity in brain ci... Read More
